President Trump Imposes Tariffs on Patented Pharmaceuticals to Strengthen U.S. Supply Chains
President Donald J. Trump has announced the imposition of tariffs on patented pharmaceutical products and their ingredients as part of a strategy to bolster national security and strengthen U.S. supply chains. The tariffs, set at 100%, will be implemented in 120 days for large companies and 180 days for smaller companies. Products from the European Union, Japan, Korea, Switzerland, and Liechtenstein will face a 15% tariff, while those from the United Kingdom will have a lower tariff due to a recent agreement. The move follows an investigation under Section 232 of the Trade Expansion Act of 1962, which found that imports of pharmaceuticals threaten U.S. national security. The tariffs aim to encourage domestic manufacturing and have already led to $400 billion in investment commitments from pharmaceutical companies. 
